Palantir Technologies stock: should I buy for my ISA?

Palantir Technologies stock is on fire. In the space of just a few weeks, its share price has surged from $11 to $28 – a gain of more than 150%.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Palantir Technologies stock (NYSE: PLTR) is on fire right now. In the space of just a few weeks, its share price has surged from $11 to $28 – a gain of more than 150%.

As a result of this incredible share price rise, PLTR – which listed on the New York Stock Exchange in late September – is getting a lot of attention from investors. Should I buy this new technology stock? Let’s take a look at the investment case.

Palantir Technologies: what does it do?

Palantir is a technology company founded in 2003. Specialising in big data analytics, it builds software that lets organisations condense all their data onto one platform. This makes it easier for them to make crucial decisions.

Palantir has a total of around 125 customers across a range of industries. Its solutions help financial institutions with risk management, healthcare companies with drug development, and automakers with production efficiency. Here in the UK, its software has been used by the NHS to distribute personal protective equipment (PPE) across the country more efficiently during Covid-19.

What I find particularly interesting however, is that its platforms are used by a number of US government agencies, including the FBI and the CIA. These agencies use PLTR’s products to defend against evolving threats to national security. Selling software to these kinds of government agencies is not an easy task. This suggests to me that Palantir has some very good products.

Two colleagues working on new global financial strategy plan using tablet and laptop.

Strong growth

Looking at Palantir’s financials, growth has been impressive recently. For the third quarter of 2020, revenue was up 52% year-on-year to $289.4m. As a result of this strong performance, the company increased its guidance for full-year revenue to around $1.07bn. That will represent growth of 44% over the prior year.

It’s worth pointing out that the group did incur a loss from operations of $847.8m for Q3. However, when adjusting for $847m million in stock-based compensation, $20.2m in related employer payroll taxes, and $53.7m in expenses related to the listing, income from operations was $73.1m.

Valuation

What about the valuation? Is this another expensive growth stock? The answer here is yes, it’s expensive.

After Palantir’s recent share price surge, it now sports a market-cap of around $48bn. That puts the stock on a price-to-sales ratio of 45. That’s very high. It adds risk to the investment case. At least one short seller expects the share price to fall substantially.

Insiders are selling 

It’s worth noting that since Palantir listed on the NYSE, a number of top-level insiders, including CEO Alexander Karp, co-founder and president Stephen Cohen, co-founder and chairman Peter Thiel, and CFO David Glazer have offloaded stock. Combined, these insiders have sold over $100m worth of PLTR stock. Would they have sold that much if they were convinced the share price is going to rise higher?

Should I buy PLTR?

I think Palantir looks interesting. In today’s data-driven world, it appears well-placed for success. The long-term growth potential appears to be significant.

That said, I do have my concerns over the valuation after the recent share price spike. After rising 150%+ in just a few weeks, there’s downside risk.

Weighing everything up, I’m going to keep Palantir stock on my watchlist for now. At present, I think there are better stocks to buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »